Drug Database
Back to search

Switzerland· 60326001

Votrient 200 mg, Filmtabletten

A pazopanib product containing pazopanibum, registered in Switzerland by Novartis Pharma Schweiz AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L01XE11

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedVotrient 200 mg, FilmtablettenATCL01XE11REGISTER NO.60326001PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pazopanibumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pazopanib is registered in 2 of 19 countries.

Countries holding a registration under ATC L01XE11 (pazopanib), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 1 of them publish a price we can compare per daily dose
Search pazopanib products by name

Pazopanib · ATC L01XE11

2 / 19 countries

  • Ireland
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
pazopanibum
Manufacturer
Novartis Pharma Schweiz AG
Country
Switzerland (CH)
ATC code
L01XE11
ATC class
Pazopanib
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680603260013
    30 Stk
    CHF 670.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

593 interactions on record for pazopanib.

Graded by severity as the source publishes them — 155 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pazopanib against other medicinesHow interaction checks work

Pazopanib · interactions on record

593 records

  • 155 severe
  • 428 moderate
  • 10 minor

Most severe, free to view

  • CimetidineA02BA01severe
  • RanitidineA02BA02severe
  • FamotidineA02BA03severe
  • NizatidineA02BA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pazopanib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pazopanib products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Pazopanib Devatis
  • Belgium · Pazopanib Accord, Pazopanib Eg
  • Bulgaria · Алуниб, Пазопаниб G.L. Pharma
  • Cyprus · Pazopanib Sapiens, Pazorem
  • Czechia · Pazopanib Accord, Pazopanib Sandoz
  • Germany · Pazopanib Al, Pazopanib Beta
  • Denmark · Pazopanib Accord, Pazopanib Glenmark
  • Estonia · Pazopanib Accord, Pazopanib Teva
  • Spain · Pazopanib Accord, Pazopanib Dr. Reddys
  • Finland · Pazopanib Accord, Pazopanib Glenmark
  • France · Pazopanib Accord, Pazopanib Biogaran
  • United Kingdom (Northern Ireland) · Pazopanib Accord, Pazopanib Accord Healthcare
  • Greece · Pazopanib Accord, Pazopanib Stada
  • Croatia · Pazopanib Accord, Pazopanib Frontier
  • Hungary · Pazopanib Accord, Pazopanib G.L. Pharma
  • Ireland · Pazopanib Accord, Pazopanib Reddy
  • Iceland · Pazopanib Adalvo, Pazopanib Stada
  • Italy · Pazopanib Accord, Pazopanib Dr. Reddy’s
  • Liechtenstein · Votrient
  • Lithuania · Pazopanib Accord, Pazopanib Auxilia
  • Luxembourg · Pazopanib Eg, Pazopanib Pazopanib Eg
  • Latvia · Pazopanib Accord, Pazopanib Teva
  • Malta · Pazopanib Pharmacare, Pazopanib Pharos
  • Netherlands · Pazopanib Accord, Pazopanib Cf
  • Norway · Pazopanib Accord, Pazopanib Glenmark
  • Poland · Pazopanib Accord, Pazopanib Glenmark
  • Portugal · Pazopanib Accord, Pazopanib Bluepharma
  • Romania · Pazopanib Accord, Pazopanib Dr. Reddys
  • Sweden · Pazopanib Accord, Pazopanib Glenmark
  • Slovenia · Pazopanib Accord, Pazopanib Teva
  • Slovakia · Pazopanib Accord, Pazopanib G.L. Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e01399a0-79a2-4639-801c-3ef2e95d2f64
GET /v1/drugs/e01399a0-79a2-4639-801c-3ef2e95d2f64?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "pazopanibum 200 mg",
  "valid_from": "2010-11-01",
  "limitations": "[{\"description\":\"Behandlung des fortgeschrittenen und/oder metastasierenden Nierenzellkarzinoms (RCC).<br>\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2010-11-01\"},{\"description\":\"Behandlung von Weichteilsarkomen mit Ausnahme von adipozytären Tumoren, GIST (gastrointestinalen Stromatumoren), nicht-alveolären und nicht-pleomorphen Rhabdomyosarkomen, primitiven neuroektodermalen Tumoren, inflammatorischem myofibroblastischem Sarkom, malignem Mesotheliom und gemischten mesodermalen Tumoren des Uterus.<br>\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2013-05-01\"}]",
  "galenic_form": "Filmtabl 200 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2010-11-01",
  "self_retention_pct": 40
}
API referenceMCP serverPlans

See everything about pazopanib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console